REFERENCES
- Cronin KJ, Williams NN, Kerin MJ, et al. Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma. J Urol 1994; 152: 834–836.
- Figge C, Reifenberger G, Vogeley KT, Messing M, Roosen N, Wechsler W. Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance. J Cancer Res Clin Oncol 1992; 118: 289–295.
- Grignon DJ, Ayala AG, El-Naggar A, et al. Renal cell carcinoma. A clinico-pathologic and DNA flow cytometric analysis of 103 cases. Cancer 1989; 64: 2133–2140.
- Hall PA, Levinson DA, Wood AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalisation in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol 1990; 162: 285–289.
- Harper ME, Glynne-Jones L, Goddard L, et al. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate 1992; 20: 243–253.
- Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991; 44: 655–659.
- Larsson P, Roos G, Stenling R, Ljungberg B. Tumor cell proliferation and prognosis in renal cell carcinoma. Int J Cancer 1993; 55: 566–570.
- Linden WA, K—Ilermann M, König K. Flowcytometric and autoradiographic studies of human kidney carcinomas surgically removed after preirradiation. Br J Cancer 1980; 41: 177–180.
- Ljungberg B, Larsson P, Roos G, Stenling R, Wilson G. Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry. J Urol 1994; 151: 1509–1513.
- Ljungberg B, Stenling R, Roos G. DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer 1985; 56: 503–508.
- Ljungberg B., Stenling R., Roos G. Prognostic value of the deoxyribonucleic acid content in metastatic renal cell carcinoma. J Urol 1986; 136: 801–804.
- Malmström PU, Wester K, Vasko J, Busch C. Expression of PCNA in urinary bladder carcinoma. Evaluation of antigen retrieval methods. APMIS 1992; 100: 151–158.
- Mathews MB, Bernstein RM, Franza BR, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984; 303: 374–376.
- Morris GF, Mathews MB Regulation of proliferating cell nuclear antigen during the cell cycle,. J Cell Biol 1989; 264: 13856–13858.
- Oka K, Hoshi T, Arai T. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone. Cancer 1992; 70: 1545–1549.
- Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301.
- Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971; 28: 1165–1177.
- Skopelitou A, Korkolopoulou P, Papanicolaou A, Christodoulou P, Thomas-Tsagli E, Pavlakis K. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Eur Urol 1992; 22: 235–240.
- Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genitourinary neoplasms. World J Urol 1987; 5: 108–122.
- Villari D, Nicita G, Ponchietti R, et al. Tumor proliferative fraction in renal cell carcinoma. A comparative study of PCNA immunostaining and flow cytometry. Proceeding, European Association of Urology, XIth congress, 1994; p. 252.
- Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conversion and the detection of a nucleolar form. J Cell Sci 1990; 90: 121–125.